| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 14,158 | 13,013 | 12,797 | 13,538 | | Cost of Revenue | 11,751 | 11,153 | 11,604 | 13,249 | | | Gross Profit | 2,407 | 1,860 | 1,193 | 289 | | | Operating Expenses | | Research Development | 1,978 | 1,997 | 1,338 | 1,272 | | Selling General and Administrative | 1,947 | 1,571 | 1,561 | 2,088 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,517) | (1,707) | (1,706) | (3,071) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 39 | | Earnings Before Interest And Taxes | (1,538) | (1,707) | (1,706) | (3,033) | | Interest Expense | (17) | 7 | 9 |
-
| | Income Before Tax | (1,521) | (1,715) | (1,715) | (3,033) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,521) | (1,715) | (1,715) | (3,033) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,521) | (1,715) | (1,715) | (3,033) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,521) | ($1,715) | ($1,715) | ($3,033) |
|
0.01% Nasdaq 0.00%
Income Statement
